BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

OmicEra Diagnostics (acquired by Exact Sciences)

OmicEra Diagnostics logo

Website
https://www.omicera.com/
Founded
2019

Technologies

AI Companies (Drug Discovery)

OmicEra is a leading proteomics and artificial intelligence (AI) startup, dedicated to revolutionize medical diagnostics using high-end mass spectrometry-based proteomics and improve human health. Transparency, reproducible results and open-source software development are deeply integrated into the culture. Their goal is to unravel the secrets fromthe proteome to digitalize a person’s health state.

Proteomics Mass Spectrometry Biomarker Discovery

R&D Platform

OmicEra offers cutting-edge MS-based proteome analyses of human samples: ranging from plasma, CSF or urine to any type of FFPE and frozen tissue collection. Powered by innovative AI technology, our results maximize the insight from samples. This helps our clients to improve their research pipelines and discover more reliable and valuable biomarkers.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.